Literature DB >> 15895459

Gastric cancer: new genetic developments.

Henry T Lynch1, William Grady, Gianpaolo Suriano, David Huntsman.   

Abstract

Gastric cancer's (GC) incidence shows large geographic differences worldwide with the lowest rates occurring in most Western industrialized countries including the United States and the United Kingdom; in contrast, relatively high rates of GC occur in Japan, Korea, China, and South America, particularly Chile. The Laurén classification system classifies GC under two major histopathological variants: 1) an intestinal type and 2) a diffuse type. The intestinal type is more common in the general population, more likely to be sporadic and related to environmental factors such as diet, particularly salted fish and meat as well as smoked foods, cigarette smoking, and alcohol use. It exhibits components of glandular, solid, or intestinal architecture, as well as tubular structures. On the other hand, the diffuse type is more likely to have a primary genetic etiology, a subset of which, known as hereditary diffuse gastric cancer (HDGC), is due to the E-cadherin (CDH1) germline mutation. The diffuse type pathology is characterized by poorly cohesive clusters of cells which infiltrate the gastric wall, leading to its widespread thickening and rigidity of the gastric wall, known as linitis plastica. Helicobacter pylori infection is associated with risk for both the intestinal and diffuse varieties of gastric cancer. Germline truncating mutations of the CDH1 gene, which codes for the E-cadherin protein, were initially identified in three Maori families from New Zealand that were predisposed to diffuse GC. Since then, similar mutations have been described in more than 40 additional HDGC families of diverse ethnic backgrounds. It is noteworthy that two-thirds of HDGC families reported to date have proved negative for the CDH1 germline mutation. A number of candidate genes have been identified through analysis of the molecular biology of E-cadherin. Patients with evidence of the CDH1 germline mutation in the context of a family history of HDGC must be considered as candidates for prophylactic gastrectomy, given the extreme difficulty in its early diagnosis and its exceedingly poor prognosis when there is regional or distant spread. Specifically, the E-cadherin cytoplasmic tail interacts with catenins, assembling the cell-adhesion complex involved with E-cadherin mediated cell:cell adhesion. Beta-catenin and gamma-catenin compete for the same binding site on the E-cadherin cytoplasmic tail, directly linking the adhesion complex to the cytoskeleton through alpha-catenin. Beta-catenin gene (CTNNB1) mutations have been described predominantly in intestinal-type gastric cancers and CTNNB1 gene amplification and overexpression have recently been described in a mixed-type gastric cancer. This paper reviews the genetics of both intestinal and diffuse types of gastric carcinoma, their differential diagnosis, molecular genetics, pathology, and, when known, their mode of genetic transmission within families. Copyright 2005 Wiley-Liss, Inc

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895459     DOI: 10.1002/jso.20214

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  57 in total

Review 1.  A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.

Authors:  Rajini Seevaratnam; Natalie Coburn; Roberta Cardoso; Matthew Dixon; Alina Bocicariu; Lucy Helyer
Journal:  Gastric Cancer       Date:  2011-12-10       Impact factor: 7.370

2.  Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Bülent Arman Aksoy; Do Joong Park; Nikolaus Schultz; Sandra W Ryeom; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

3.  Global research on Helicobacter pylori.

Authors:  Barik A Salih; Fatih M Ipek
Journal:  Dig Dis Sci       Date:  2007-01       Impact factor: 3.199

4.  Scintigraphic appearance of "linitis plastica" in a patient with gastric non-Hodgkin's lymphoma on 18F-FDG imaging.

Authors:  Ilknur Ak; Burcu Aydemir; Zafer Gülbaş
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05       Impact factor: 9.236

Review 5.  Recognition of and recent issues in hereditary diffuse gastric cancer.

Authors:  Shinya Sugimoto; Hirokazu Komatsu; Yuichi Morohoshi; Takanori Kanai
Journal:  J Gastroenterol       Date:  2015-06-07       Impact factor: 7.527

Review 6.  [Prophylactic surgery for hereditary non-polyposis colorectal cancer].

Authors:  G Möslein; C Ohmann; M Wenzel
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

Review 7.  An evidence-based review of the surgical treatment of gastric adenocarcinoma.

Authors:  Ugwuji N Maduekwe; Sam S Yoon
Journal:  J Gastrointest Surg       Date:  2011-03-12       Impact factor: 3.452

8.  Germline mutations in hereditary diffuse gastric cancer.

Authors:  Hao Zhang; Mengmeng Feng; Yi Feng; Zhaode Bu; Ziyu Li; Shuqin Jia; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

Review 9.  Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.

Authors:  Lin Ding; Mohamad El Zaatari; Juanita L Merchant
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 10.  Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.

Authors:  Henry T Lynch; Edibaldo Silva; Debrah Wirtzfeld; Pamela Hebbard; Jane Lynch; David G Huntsman
Journal:  Surg Clin North Am       Date:  2008-08       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.